Rankings
▼
Calendar
IRWD Q3 2024 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IRWD
Ironwood Pharmaceuticals, Inc.
$629M
Q3 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$92M
-19.5% YoY
Gross Profit
$62M
67.4% margin
Operating Income
$26M
28.0% margin
Net Income
$4M
4.0% margin
EPS (Diluted)
$0.02
QoQ Revenue Growth
-3.0%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$10M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$390M
Total Liabilities
$701M
Stockholders' Equity
-$311M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$92M
$114M
-19.5%
Gross Profit
$62M
$113M
-45.5%
Operating Income
$26M
$49M
-47.3%
Net Income
$4M
$15M
-76.2%
Revenue Segments
Royalty
$700,000
52%
Collaborative arrangement, collaboration and license agreements
$413,000
31%
Collaborative arrangement, other agreements
$222,000
17%
Geographic Segments
North America
$89M
99%
Europe and Other
$807,000
1%
← FY 2024
All Quarters
Q4 2024 →